Corcept Therapeutics (CORT) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $117.17 +2.36%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q2 EPS of $0.25, $0.10 better than the analyst estimate of $0.15. Revenue for the quarter came in at $117.7 million versus the consensus estimate of $109.6 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
